Home / SPSB1 Knockout Cell Lines

SPSB1 Knockout Cell Lines

Gene: SPSB1

Official Full Name: splA/ryanodine receptor domain and SOCS box containing 1provided by HGNC

Gene Summary: Enables ubiquitin-like ligase-substrate adaptor activity. Involved in protein ubiquitination and ubiquitin-dependent protein catabolic process. Located in cytosol. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO00431 SPSB1 Knockout cell line (HCT 116) Human SPSB1 1:2~1:4 Negative Online Inquiry
KO26163 SPSB1 Knockout cell line (HeLa) Human SPSB1 1:3~1:6 Negative Online Inquiry
KO26164 SPSB1 Knockout cell line (HEK293) Human SPSB1 1:3~1:6 Negative Online Inquiry
KO26165 SPSB1 Knockout cell line (A549) Human SPSB1 1:3~1:4 Negative Online Inquiry

Background

SPSB1 Gene Knockout Cell Lines are genetically modified cellular models that have been engineered to lack the functional expression of the SPSB1 gene, which encodes for suppressor of cytokine signaling box 1 protein. These cell lines serve as essential tools for exploring the complex biochemical pathways that involve the regulation of cell signaling, particularly in response to various cytokines. By eliminating SPSB1, researchers can investigate its role in processes such as apoptosis, immune response modulation, and cell proliferation, which are critical in understanding many pathological conditions.

The mechanism underlying the function of these knockout cell lines lies in their ability to reveal compensatory pathways and alternative signaling routes that may be activated when the SPSB1 gene is absent. This enables researchers to delineate the specific contributions of SPSB1 to cellular homeostasis and cytokine signaling, thereby bridging the gaps in knowledge regarding cell fate and behavior.

The scientific importance of SPSB1 Gene Knockout Cell Lines is particularly pronounced in both basic and applied research. They provide invaluable insights into diseases where dysregulation of cytokine signaling is implicated, including cancers, autoimmune disorders, and metabolic syndromes, facilitating the development of targeted biochemical therapies and novel therapeutics.

In comparison to alternative models, such as transient knockdown approaches, these stable knockout cell lines offer consistent and reproducible results, allowing for long-term studies and the generation of reliable data over time. Additionally, their genetic stability enhances experimental validity by minimizing variability that could arise from heterogeneous cell populations.

For researchers and clinicians, the profound implications of utilizing SPSB1 Gene Knockout Cell Lines cannot be overstated; they enhance the understanding of fundamental biological processes and inform the development of innovative treatment strategies. With our extensive experience in the field and commitment to quality, our company provides these advanced cell lines alongside comprehensive support, ensuring that researchers can effectively leverage this technology for cutting-edge breakthroughs in their work.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.